Skip to main content
Premium Trial:

Request an Annual Quote

Idaho Technology, Applied Biosystems in Cross-licensing Deal

NEW YORK (GenomeWeb News) – Idaho Technology and Life Technologies' Applied Biosystems business have entered into a cross-licensing pact covering instrument, software, and reagents, Idaho Technology said today.

The licensing deal includes patents that relate to real-time polymerase chain reaction methods and instrumentation, including the 5' nuclease process SYBR Green I in PCR reactions. More specific details and financial terms of the agreement were not disclosed.

The cross-licensing pact "enables innovation in a more open environment that is good for business and ultimately benefits customers," Randy Rasmussen, president of Idaho Technology, said in a statement.

Salt Lake City-based Idaho Technology is privately held and licensed the rapid PCR technology from the University of Utah. It created the LightCycler PCR-based instrument, which it sublicensed to Roche Diagnostics.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.